Click to Share
 
 
  1. Latest News
  2. Submit Press Release

biomedical Press Releases

  + XML/RSS  



By Imaginology
iPad app for surgical device doubles time spent with surgical device brand and drives 4th quarter success
By Karl McMahon
Alexander's Inc. (NYSE:ALX) announced that its Board of Directors has declared an increased quarterly dividend of $3.00 per share (a new indicated annual rate of $12.00).
By Karl McMahon
Enzo Biochem, Inc. (NYSE:ENZ) is a leading life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and provides reference laboratory services to the medical community.
By Karl McMahon
Enzo Biochem, Inc. (NYSE:ENZ) is a leading life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and provides reference laboratory services to the medical community.
By Karl McMahon
Enzo Biochem, Inc. (NYSE:ENZ) is a leading life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and provides reference laboratory services to the medical community.
By Karl McMahon
Enzo Biochem, Inc. (NYSE:ENZ) is a leading life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and provides reference laboratory services to the medical community.
By Karl McMahon
Enzo Biochem, Inc. (NYSE:ENZ) is a leading life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and provides reference laboratory services to the medical community.
By Karl McMahon
American Video Teleconferencing Corp. (Pink Sheets:AVOT) is pleased to announce that it has hired a French speaking geologist to search the archives of the Quebec Department of Mines for Rare Earths showings not on a current computer file.
By Karl McMahon
Enzo Biochem, Inc. (NYSE:ENZ) is a leading life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and provides reference laboratory services to the medical community.
By Lynn Lumpkin
Enzo Biochem, Inc. (NYSE:ENZ) reported improved sequential results for the first fiscal quarter ended October 31, 2010, the result of recent programs to reduce expenses, consolidate activities and expand operations.
By Karl McMahon
Enzo Biochem, Inc. (NYSE:ENZ) is a leading life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and provides reference laboratory services to the medical community.
By Fast Market Research
Recently published research from GlobalData, "Chronix Biomedical, Inc. - Product Pipeline Analysis", is now available at Fast Market Research
By Karl McMahon
American Video Teleconferencing Corp. (Pink Sheets:AVOT) is presently in final discussions to enter into a formal agreement to acquire an exclusive option on a molybdenum property in the Otter lake area in the province of Quebec, Canada.
By Lynn Lumpkin
PWRM pursues an aggressive intellectual property strategy to protect its inventions and discoveries made on its own and with its collaborators.
By Karl McMahon
Enzo Biochem, Inc. (NYSE:ENZ) is a leading life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and provides reference laboratory services to the medical community.
By Fast Market Research
New Healthcare market report from Business Monitor International: "Singapore Pharmaceuticals Competitive Intelligence Report Q4 2010"
By Greg Lumpkin
PWRM pursues an aggressive intellectual property strategy to protect its inventions and discoveries made on its own and with its collaborators.
By Blayne Sheffield
PWRM.OB, HMA, RDN, & NVE: NV Energy, Inc. Reports Third Quarter Earnings
By Blayne Sheffield
Power3 has filed several patent applications for its NuroPro® technology that are currently pending. Power3 also has a world-wide exclusive license from the Baylor College of Medicine in Houston, Texas.
By Blayne Sheffield
NRO, ULU, SA, & PWRM.OB: Drills Upgrading Large Resource at Seabridge Gold's Courageous Lake Project
By Blayne Sheffield
PWRM.OB, ILMN, & VSYM.OB: ILMN has recently reported the production of the Eco Real-Time PCR System
By Blayne Sheffield
PWRM, MNTA, & SNY: Raul E. Kohan will be appointed Chief Executive Officer
By Blayne Sheffield
MNTA, GENZ, & PWRM.OB: Biotech Stocks: Onyx, Genzyme, Momenta in spotlight
By Blayne Sheffield
GENZ, PWRM, & SNY: Blink on Friday And Miss Massive Biotech Spikes
By MedTech
MedTech members attended the Bio-Industry Breakfast at the inaugural conference of the International Institute of the Biomedical Sciences and Technology (IIBMST)
By Blayne Sheffield
PWRM, ILMN, & CAH: Sequenom Rises as Ladenburg Says Buy, Jefferies Starts at Hold
By MedTech
The MEDTECH 2010 annual conference—Surging Ahead: Thriving in the New Healthcare Market—will be held Monday, October 4 at the Lodge in Skaneateles Falls, N.Y.
By Blayne Sheffield
AFFX, LIFE, & OTC:PWRM: Affymetrix Launches Axiom Custom Genotyping Arrays Utilizing World's Largest Validated SNP Database
By Blayne Sheffield
SNY, GSK, & OTC:PWRM: Weekly Pharma Roundup: GSK Settles, Vivus Disappoints, Ely Lilly Axes
By Blayne Sheffield
Molecular Insight Pharmaceuticals is a clinical-stage biopharmaceutical company and a pioneer in the emerging field of molecular medicine. The Company is focused on the discovery.
By TIME MEDICAL
Time Medical recognized as the company with innovative MR systems utilizing patented High Temperature Superconducting (HTS) RF Coils to deliver superior MR image quality.
By Blayne Sheffield
Affymetrix GeneChip® microarray technology is the industry-standard tool for analyzing complex genetic information.
By crwepicks
PWRM is now available for $0.039 cents a share with an RSI creeping closer to 30 which could be interpreted as a time to buy. Since the beginning of June 2010 PWRM has been trading in a channel.
By Blayne Sheffield
Amgen Inc. is a biotechnology medicines company, discovers, develops, manufactures, and delivers human therapeutics based on advances in cellular and molecular biology primarily in the United States
By crwepicks
Cyclacel's cancer drug gets FDA orphan status: PWRM, SIGA, & CYCC
By crwepicks
Crawford, Molecular Insight Pharmaceuticals: Biggest Price Decliners (CRDB, MIPI)
By crwepicks
PWRM is now available for $0.04 cents a share with an RSI creeping closer to 30 which could be interpreted as a time to buy. Since the beginning of June 2010 PWRM has been trading in a channel.
By crwepicks
PWRM is now available for $.04 cents a share. Since the beginning of June 2010 PWRM has been trading in a channel. Pay attention for a possible breakout. A breakout could be an indicator of possible momentum.
By crwepicks
The intellectual property that Power3 has and continues to pursue today covers the product areas of breast cancer, neurodegenerative diseases, and drug resistance.
By Editorial Staff
CEMI, QTXB, SGYP-Late Morning Biomedical Stock Picks. SimonSaysStocks.com provides you with the most up-to-date penny stock alerts, Join now for more free penny stock alerts.
By crwepicks
Albany Molecular Research Inc. announced today that its board of directors has approved a new share repurchase program of up to $10 million
By crwepicks
Recent news of Arrowhead's research expecting to raise to $8.7M has brought some interest to their stock. Volume is just under the 3 month average but it's share prices are steadily going up.
By crwepicks
has been trading in a channel. Pay attention for a possible breakout. PWRM deserves to be watched very closely! A breakout could be an indicator of possible momentum.
By crwepicks
Medical Update for 3 Major Medical Companies
By crwepicks
PWRM is now available for $0.038 cents a share with an RSI creeping closer to 30 which could be interpreted as a time to buy. Since the beginning of June 2010 PWRM has been trading in a channel. Pay attention for a possible breakout.
By Edmund Optics
Amber Czajkowski, a thin-films engineer at Edmund Optics, will speak on “Illumination for Surgery and Medical Diagnosis” at the Symposium on Advanced Bio-optics and Related Medical Device Regulatory Considerations in Hong Kong on April 16, 2010.
By Florida High Tech Corridor Council
Magazine Offers Compelling Stories about Florida’s High Tech Corridor, its Researchers, Entrepreneurs and Technology Breakthroughs through online video channel, www.facesoftechnology.com
By RayBiotech, Inc.
RayBiotech, Inc., today announced that they are extending the deadline for submitting applications for its Biomarker Discovery Pilot Grant program. RayBiotech will now accept applications for the pilot grants through February 22nd, 2010.
By OTCMarketBulls.com
Conexant Systems, Inc. (NASDAQ: CXNT) +14.24%, Anadys Pharmaceuticals, Inc. (NASDAQ: ANDS) +7.21%, Intuitive Surgical, Inc. (NASDAQ: ISRG) +12.50%, Somaxon Pharmaceuticals, Inc. (NASDAQ: SOMX) +111.36%
By OTCMarketBulls
OTCMB's Morning Stocks Making the News include Vivakor Inc (VIVK) and CAVU Resources, Inc (CAVR)



Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share